Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2019 from OUS - Section for Cancer Cytogenetics

9 publications found

Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
Clin Nucl Med, 44 (8), 605-611
DOI 10.1097/RLU.0000000000002641, PubMed 31274605

Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F (2019)
Molecular characterization of carcinosarcomas arising in the uterus and ovaries
Oncotarget, 10 (38), 3614-3624
DOI 10.18632/oncotarget.26942, PubMed 31217897

Brunetti M, Panagopoulos I, Micci F, Davidson B (2019)
MGMT promoter methylation is a rare epigenetic change in malignant effusions
Cytopathology, 31 (1), 12-15
DOI 10.1111/cyt.12782, PubMed 31808217

Panagopoulos I, Gorunova L, Andersen HK, Pedersen TD, Lømo J, Lund-Iversen M, Micci F, Heim S (2019)
Genetic Characterization of Myoid Hamartoma of the Breast
Cancer Genomics Proteomics, 16 (6), 563-568
DOI 10.21873/cgp.20158, PubMed 31659109

Panagopoulos I, Gorunova L, Lobmaier I, Lund-Iversen M, Andersen K, Holth A, Bjerkehagen B, Heim S (2019)
Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma
Cancer Genomics Proteomics, 16 (5), 361-368
DOI 10.21873/cgp.20141, PubMed 31467230

Panagopoulos I, Gorunova L, Lund-Iversen M, Bassarova A, Heim S (2019)
Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma
Cancer Genomics Proteomics, 16 (5), 345-351
DOI 10.21873/cgp.20139, PubMed 31467228

Panagopoulos I, Lobmaier I, Gorunova L, Heim S (2019)
Fusion of the Genes WWTR1 and FOSB in Pseudomyogenic Hemangioendothelioma
Cancer Genomics Proteomics, 16 (4), 293-298
DOI 10.21873/cgp.20134, PubMed 31243110

Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
Pediatr Blood Cancer, 66 (10), e27910
DOI 10.1002/pbc.27910, PubMed 31264356

Torkildsen S, Gorunova L, Heim S, Tjønnfjord GE, Spetalen S, Risberg B, Tran HTT, Panagopoulos I (2019)
Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality
Cancer Genomics Proteomics, 16 (3), 175-178
DOI 10.21873/cgp.20123, PubMed 31018948

 
Page visits: 595730